CNCE NASDAQ
Concert Pharmaceuticals, Inc.
1W: -0.1%
1M: -0.2%
3M: +73.7%
1Y: +171.8%
3Y: -12.0%
5Y: -60.2%
$8.37
Last traded 2023-03-03 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-99.8% YoY
$-66M
Net Income
-0.2% YoY
$-110M
Free Cash Flow
-143.4% YoY
100.0%
Gross Margin
-370075.0%
Op. Margin
-352525.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-57.2%
ROA-44.4%
ROIC2651.1%
Valuation
P/E-3.5
P/B2.6
EV/EBITDA-2.9
Leverage
Debt/Equity0.11
Current Ratio9.03
Interest Cov.-40.4x
Quality Scores
Piotroski F2/9
Altman Z1.34
Beneish M202.02